Published on December 6, 2017
What’s new in the laboratory for essential thrombocythemia and polycythemia vera research? What is the long-term potential for treating myeloproliferative neoplasms (MPNs) in the future? Andrew Schorr reports from the Cancer Research and Treatment Fund’s Annual Conference for MPN Patients with Dr. Joseph Scandura, an MPN researcher and clinician. Watch as Dr. Scandura provides details MPN research on stem cell transplants and how research can be moved forward.